Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Per the terms of the Proposed Transaction, Psyence Biomed will issue to Psyence Group shares of its common stock valued at $1.1 million dollars, at a price of $0.55 per share, in exchange for Psyence ...

Israel stocks were lower after the close on Thursday, as losses in the Biomed, Real Estate and Banking sectors led shares ...

Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced that it has entered into a conditional share sale agreement with Psyence Group (CSE: PSYG) (as seller) for the ...

“We are excited about Petra joining our team as Brand Ambassador. Her broad and deep experience will be invaluable to us as we bring our next generation colorectal cancer screening product to market, ...

As the only brand in India to offer this potent blend, Glutone, a flagship brand of Adroit Biomed Ltd., has carefully curated this innovative formula to deliver transformative results. Now you can ...

A string of troubling headlines have hit the Emeryville Life Science sector in recent months. In July, the SF Business Times ...

Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology ...

Psyence Biomedical Ltd. (NASDAQ:PBM) announced a major milestone on Monday with the initiation of the first clinical trial ...

The monoclonal antibody could serve as an emergency treatment for future outbreaks, opening the possibility of broader, more ...

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains.

Psyence Biomed will issue $500,000 in common shares to Clairvoyant's shareholders upon closing, with additional share-based payments of up to $500,000 tied to pre-specified milestones by December ...